pharmalot· @pharmalot · X·· 17 小时前AI 评分40
AI 导读
用于对抗肥胖的新型GLP-1药物可能成为下一个全球药品可及性之争的战场…… https://www.statnews.com/pharmalot/2026/11/16/semaglutide-obesity-glp1-access-medicines-low-income-countries/ #weight #obesity #semaglutide #generics #pharma #medicine
正文
Newer GLP-1 drugs to combat obesity may become the next global battleground over access to a medicine... https://www.statnews.com/pharmalot/2026/11/16/semaglutide-obesity-glp1-access-medicines-low-income-countries/ #weight #obesity #semaglutide #generics #pharma #medicine
来源:pharmalot · x.com